Haiyan Qu

Prof. Dr. Haiyan Qu

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Bioresource Technology
Verified
Journal Article
Closed access
JTJin Mi Triolo
Jin Mi Triolo
LPLene Pedersen
Lene Pedersen
HQHaiyan Qu
Haiyan Qu
SSSven Gjedde Sommer
Sven Gjedde Sommer

1 February 2018 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
XLXiaoli Liu
Xiaoli Liu
LNLine Hagner Nielsen
Line Hagner Nielsen
SKSylvia Natalie Kłodzińska
Sylvia Natalie Kłodzińska
HNHanne Morck Nielsen
Hanne Morck Nielsen
HQHaiyan Qu
Haiyan Qu
MYMingshi Yang
Mingshi Yang

11 October 2010 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Open access
PDF file
FTFang Tian
Fang Tian
HQHaiyan Qu
Haiyan Qu
AZAnne Zimmermann
Anne Zimmermann
TMTommy Munk
Tommy Munk
AJAnna C. Jørgensen
Anna C. Jørgensen
JRJukka Rantanen
Jukka Rantanen
Objectives: To provide a comprehensive understanding of the competing thermodynamic and kinetic factors governing the crystallization of various hydrate systems. The ultimate goal is to utilize this understanding to improve the control over the unit operations involving hydrate formation, as well as to optimize the bioavailability of a given drug product. Key findings: The thermodynamic and kinetic factors that govern hydrate crystallization are introduced and the current status of the endeavour to gain a mechanistic understanding of the phenomena that occur during the crystallization of different hydrate systems is discussed. The importance of hydrate investigation in the pharmaceutical field is exemplified by examining two specific hydrate systems: the polymorphic hydrate system and hydrates of pharmaceutical salts. Summary: This review identifies the factors that are of critical importance in the investigation of anhydrate/hydrate systems. This knowledge can be used to control the phase transformation during pharmaceutical processing and storage, as well as in building a desired functionality for the final formulation.

4 August 2006 in Crystal Growth & Design
Verified
Journal Article
Closed access
HQHaiyan Qu
Haiyan Qu
MLMarjatta Louhi-Kultanen
Marjatta Louhi-Kultanen
JRJukka Rantanen
Jukka Rantanen
JKJuha Kallas
Juha Kallas

1 September 2006 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
HQHaiyan Qu
Haiyan Qu
MLMarjatta Louhi-Kultanen
Marjatta Louhi-Kultanen
JKJuha Kallas
Juha Kallas

1 June 2009 in Journal of Crystal Growth
Verified
Journal Article
Closed access
HQHaiyan Qu
Haiyan Qu
HAHannu Alatalo
Hannu Alatalo
HHHenry Hatakka
Henry Hatakka
JKJarno Kohonen
Jarno Kohonen
MLMarjatta Louhi-Kultanen
Marjatta Louhi-Kultanen
JKJuha Kallas
Juha Kallas